Biocon Limited
BIOCON
Pozycja w akcjach
#3436
Biocon Limited functions as a biopharmaceutical firm, engaged in the production... Biocon Limited functions as a biopharmaceutical firm, engaged in the production of pharmaceutical, medicinal chemical, and plant-derived products. Its business activities are organized into distinct segments: Generics, Novel Biologics, Biosimilars, and Research Services. The company dedicates its efforts to crucial therapeutic domains, including diabetes, oncology, immunology, ophthalmology, and bone health disorders. Furthermore, Biocon provides comprehensive services encompassing the discovery, development, and manufacturing of both small and large molecules. With a wide international presence, it caters to customers in roughly 120 nations. Headquartered in Bengaluru, India, Biocon Limited commenced operations in 1978.
Cena akcji
$3.68
Ostatnia synchronizacja: 2026-10-21
Kapitalizacja rynkowa
$5.03B
Zmiana (1 dzień)
-1.91%
Zmiana (1 rok)
-11.51%
Kraj
IN
Handel Biocon Limited (BIOCON)
Kategoria
Healthcare
Historia ceny akcji dla Biocon Limited (BIOCON)
Najwyższa cena zamknięcia: $3.90 dnia 2026-10-01
Najniższa cena zamknięcia: $1.16 dnia 2004-04-01
Najniższa cena zamknięcia: $1.16 dnia 2004-04-01
Historia cen akcji firmy Biocon Limited od 2004 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2026 (TTM) | -0.40% |
| 2025 | 3.10% |
| 2024 | 43.03% |
| 2023 | -9.84% |
| 2022 | -32.34% |
| 2021 | -21.74% |
| 2020 | 51.69% |
| 2019 | -7.50% |
| 2018 | 8.33% |
| 2017 | 76.96% |
| 2016 | 90.65% |
| 2015 | 2.58% |
| 2014 | 4.05% |
| 2013 | 29.61% |
| 2012 | -4.48% |
| 2011 | -38.93% |
| 2010 | 49.26% |
| 2009 | 165.57% |
| 2008 | -69.07% |
| 2007 | 80.35% |
| 2006 | -25.48% |
| 2005 | -5.27% |
| 2004 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.09 | -4.30% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
